Levels of brain‐derived neurotrophic factor in patients with multiple sclerosis

OBJECTIVE: To determine the levels of brain‐derived neurotrophic factor (BDNF) in the serum of patients suffering from multiple sclerosis (MS) to evaluate the potential of serum BDNF as a biomarker for MS. METHODS: Using a recently validated enzyme‐linked immunoassay (ELISA) we measured BDNF in pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Naegelin, Yvonne, Saeuberli, Katharina, Schaedelin, Sabine, Dingsdale, Hayley, Magon, Stefano, Baranzini, Sergio, Amann, Michael, Parmar, Katrin, Tsagkas, Charidimos, Calabrese, Pasquale, Penner, Iris Katharina, Kappos, Ludwig, Barde, Yves‐Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664260/
https://www.ncbi.nlm.nih.gov/pubmed/33031634
http://dx.doi.org/10.1002/acn3.51215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664260/
https://www.ncbi.nlm.nih.gov/pubmed/33031634
http://dx.doi.org/10.1002/acn3.51215

Ejemplares similares